Omnicare Inc: (NYSE: OCR)

$46.35

0.20 (0.43%)

Volume 9,964

May 22 09:41 AM ET

Zacks Rank: 2-Buy

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		46.06 - 46.39
	
		52wk Low - High
		29.24 - 46.55
	
		Previous Close
		46.15
	
		Avg. Volume
		1,019,961
	
		Industry
		MEDICAL SERVICES
	
		Market Cap
		4.83 B
	
		Div - Yield
		0.56 - 1.21
	
		Beta
		0.79
	
		PE (Forward)
		12.98
	
		Current Year Est.
		3.55
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		2
Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		105 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/17/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            12.98
                        
                            PEG Ratio
                            0.87
                        
                            Current Year Est.
                            3.55
                        
                            Current Quarter Estimate
                            0.86
                        
                            Most Accurate Estimate
                            0.86
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            07-24-2013
                        
                            EPS Last Year
                            3.45
                        
                            Expected Earnings Growth
                            15.00%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Omnicare, Inc., a Fortune five hundred company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities and other chronic care settings comprising beds in fourteen states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in thirty countries worldwide.   
Full OCR Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
OCR Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.86	0.88	3.55	3.84
Number of Estimates	5	4	5	5
Low Estimate	0.84	0.87	3.55	3.78
High Estimate	0.88	0.89	3.56	NA
Year Ago EPS	0.83	0.86	3.36	3.55
EPS Growth	3.37%	2.62%	5.77%	8.16%

More OCR Estimates

Average Earnings Estimates for OCR

EPS Growth for OCR

Industry Analysis

Name	Symbol	Previous Close
OMNICARE INC	OCR	46.15
ICON PLC	ICLR	33.36
IPC THE HOSPITL	IPCM	48.56
PAREXEL INTL CP	PRXL	46.37
ADVISORY BOARD	ABCO	51.15
BG MEDICINE INC	BGMD	1.83
CATAMARAN CORP	CTRX	50.38
CHARLES RVR LAB	CRL	44.99
COVANCE INC	CVD	76.09
EXPRESS SCRIPTS	ESRX	61.31

Sector:Medical>> Industry:MEDICAL SERVICES

COMPARE TICKER vs. Its Peers

Zacks Commentary

ABCO Posts Solid 4Q and FY2013 Earnings

May 13, 2013

Charles River Misses Estimates in 1Q

May 02, 2013

ESRX Beats 1Q Earnings & Revenues Estimate

Apr 30, 2013

OCR Beats on Earnings Est; Misses Rev

Apr 25, 2013

Company News for February 20, 2013

Feb 20, 2013

Omnicare Tops Est., Higher Profit

Feb 20, 2013

ESRX Reports In-Line 4Q Earnings

Feb 19, 2013

Mixed 4Q for Charles River

Feb 14, 2013

More OCR Zacks Commentary

Financials

EPS TTM	3.45
Sales	6,160
Net Income	193
Price/Earnings	13.38
Price/Book	1.36
Price/Cash Flow	9.91
Price/Sales	0.79

More OCR Financials

News

Shares of Omnicare Rise to a New 52-Week High - Financial News Netwfork Online - 52-Week High-Lows

May 20, 2013

Omnicare (OCR) Could Break Through $46.16 Resistance Level - Freshbrewedmedia

May 17, 2013

Omnicare: The Winning Streak Continues (OCR) - Financial News Netwfork Online - 52-Week High-Lows

May 16, 2013

Omnicare: 52-Week High Recently Eclipsed (OCR) - Financial News Netwfork Online - 52-Week High-Lows

May 14, 2013

Omnicare (OCR) Showing Support Near $44.80 With 1.23% Dividend Yield - Freshbrewedmedia

May 13, 2013

Omnicare to Present at the Bank of America Merrill Lynch 2013 Health Care Conference - Thomson Reuters One

May 10, 2013

Omnicare: 52-Week High Recently Eclipsed (OCR) - Financial News Netwfork Online - 52-Week High-Lows

May 10, 2013

Shares of Omnicare Under Pressure, Down 1.4% - Financial News Network Online - Market Movers

May 9, 2013

See All News Stories on OCR

Broker Recommendations

Current ABR	1.83
ABR (Last Week)	1.83
# of recs in ABR	6
Average Target Price	44.00
Industry Rank by ABR	105 out of 265
Rank in Industry	1 out of 15

More OCR Broker Recommendations

Day Low - High	46.06 - 46.39
52wk Low - High	29.24 - 46.55
Previous Close	46.15
Avg. Volume	1,019,961
Industry	MEDICAL SERVICES
Market Cap	4.83 B
Div - Yield	0.56 - 1.21
Beta	0.79
PE (Forward)	12.98
Current Year Est.	3.55
Quarterly Earnings ESP	0.00%

PE (Forward)	12.98
PEG Ratio	0.87
Current Year Est.	3.55
Current Quarter Estimate	0.86
Most Accurate Estimate	0.86
Earnings ESP	0.00%
Next Earnings Report Date	07-24-2013
EPS Last Year	3.45
Expected Earnings Growth	15.00%

Username: Password:

Remember me [?]

Omnicare Inc: (NYSE: OCR)

$46.35

0.20 (0.43%)

Volume 9,964

May 22 09:41 AM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description